Ga letter!!!Dear Friend;
Attached is today’s news release.
Some background:
1. Concurrent with the release of the VMS+3.0, the Company re-started manufacturing its products (VMS+2.0 was made by a contract manufacturer). This reduced costs and gave us more control.
2. Consequently, the Company now undergoes routine inspections to verify its ability to manufacture quality medical devices. Medical devices have special requirements.
3. The Company has undergone quarterly inspections and passed them all with no significant non-conformities and so it has been moved to semi-annual inspections for its excellent performance.
4. As you will read in the NR, the Company passed our most recent semi-annual inspection and is authorized to continue to sell into Canada and USA. Europe has different inspections and FYI, we are in compliance there as well.
5. While we routinely pass these inspections, it takes a concerted effort to maintain processes and updated them as regulations change (and they change often).
I know I said I was working on lots of new releases and I have, but unfortunately we are still awaiting approval of many NRs by our partners (distributors, hospitals and alliances). We will get them out as soon as we get permission.
Thanks for the continued support and interest as we complete our mission to improve cardiac diagnostics worldwide for everyone and especially for children.
Regards,
Dr. George Adams ICD.D
Executive-Chairman
Ventripoint Diagnostics Ltd.
TSXV-VPT
519-803-6937